针对接受无创正压通气的慢性高碳酸血症性慢性阻塞性肺疾病患者的严重呼吸功能不全问卷中文版。
The Chinese version of the Severe Respiratory Insufficiency questionnaire for patients with chronic hypercapnic chronic obstructive pulmonary disease receiving non-invasive positive pressure ventilation.
作者信息
Chen Rongchang, Guan Lili, Wu Weiliang, Yang Zhicong, Li Xiaoying, Luo Qun, Liang Zhenyu, Wang Fengyan, Guo Bingpeng, Huo Yating, Yang Yuqiong, Zhou Luqian
机构信息
State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
出版信息
BMJ Open. 2017 Aug 28;7(8):e017712. doi: 10.1136/bmjopen-2017-017712.
OBJECTIVES
The Severe Respiratory Insufficiency (SRI) questionnaire is the best assessment tool for health-related quality of life in patients with chronic obstructive pulmonary disease (COPD) receiving non-invasive positive pressure ventilation (NIPPV). This study aimed to translate the SRI Questionnaire into Chinese and to validate it.
DESIGN
Prospective validation study.
SETTING AND PARTICIPANTS
A total of 149 participants with chronic hypercapnic COPD receiving NIPPV completed the study.
METHODS
The SRI questionnaire was translated into Chinese using translation and back-translation. Reliability was gauged using Cronbach's α coefficient. Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were used to assess construct validity. Content validity was confirmed by evaluating the relationship between the score of each item and the total score of the relevant subscale.
RESULTS
Cronbach's α coefficients for each subscale and summary scale were above 0.7. Using EFA, one factor was extracted from the anxiety and summary scales and two factors were extracted from the remaining six subscales. Based on the EFA results, subsequent CFA revealed a good model fit for each subscale, but the extracted factors of each subscale were correlated. Content validity was confirmed by the good relationship between the score of each item and the total score of the relevant subscale.
CONCLUSION
The Chinese version of the SRI questionnaire is valid and reliable for patients with chronic hypercapnic COPD receiving NIPPV in China.
TRIAL REGISTRATION NUMBER
NCT02499718.
目的
严重呼吸功能不全（SRI）问卷是接受无创正压通气（NIPPV）的慢性阻塞性肺疾病（COPD）患者健康相关生活质量的最佳评估工具。本研究旨在将SRI问卷翻译成中文并进行验证。
设计
前瞻性验证研究。
设置与参与者
共有149名接受NIPPV的慢性高碳酸血症COPD患者完成了本研究。
方法
采用翻译和回译的方法将SRI问卷翻译成中文。使用Cronbach's α系数评估信度。采用探索性因子分析（EFA）和验证性因子分析（CFA）评估结构效度。通过评估各项目得分与相关子量表总分之间的关系来确认内容效度。
结果
各子量表和总量表的Cronbach's α系数均高于0.7。使用EFA，从焦虑量表和总量表中提取了一个因子，从其余六个子量表中提取了两个因子。基于EFA结果，随后的CFA显示每个子量表的模型拟合良好，但每个子量表提取的因子存在相关性。各项目得分与相关子量表总分之间的良好关系证实了内容效度。
结论
中文版SRI问卷在中国接受NIPPV的慢性高碳酸血症COPD患者中具有有效性和可靠性。
试验注册号
NCT02499718。
Zotero 插件